Grace Therapeutics Announces Presentation at The H.C. Wainwright 27th Annual Global Investment Conference
(NASDAQ:GRCE) PRINCETON, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a...
2 days ago